QQ客服 官方微博 反馈留言

	Association between eIF3α polymorphism and severe toxicity caused by platinum‐based chemotherapy in non‐small cell lung cancer patients
	Xu, Xiaojing; Han, Lifang; Duan, Li; Zhao, Yingchun; Yang, Huaping; Zhou, Boting; Ma, Rui; Yuan, Ruixia; Zhou, Honghao; Liu, Zhaoqian*
刊名	British Journal of Clinical Pharmacology
	2013
卷号	75期号:2页码:522-534
关键词	eIF3α nephrotoxicity non‐small cell lung cancer (NSCLC) ototoxicity platinum toxicity
ISSN号	1365-2125
DOI	10.1111/j.1365-2125.2012.04379.x
URL标识	查看原文
WOS记录号	WOS:000313554200022
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3325200
专题	中南大学
作者单位	1.[Liu, Zhaoqian 2.Xu, Xiaojing 3.Zhou, Honghao 4.Han, Lifang] Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha 410078, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Xu, Xiaojing,Han, Lifang,Duan, Li,et al. Association between eIF3α polymorphism and severe toxicity caused by platinum‐based chemotherapy in non‐small cell lung cancer patients[J]. British Journal of Clinical Pharmacology,2013,75(2):522-534.
APA	Xu, Xiaojing.,Han, Lifang.,Duan, Li.,Zhao, Yingchun.,Yang, Huaping.,...&Liu, Zhaoqian*.(2013).Association between eIF3α polymorphism and severe toxicity caused by platinum‐based chemotherapy in non‐small cell lung cancer patients.British Journal of Clinical Pharmacology,75(2),522-534.
MLA	Xu, Xiaojing,et al."Association between eIF3α polymorphism and severe toxicity caused by platinum‐based chemotherapy in non‐small cell lung cancer patients".British Journal of Clinical Pharmacology 75.2(2013):522-534.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。